Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

NCT01459588 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
315
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan